Catalent Massachusetts, LLC

Form 483 issued April 7, 2026 · Chelsea, Massachusetts

Inspection
Apr 1 – Apr 7, 2026
Observations
1
Pages
3
FEI number
3011696115

In short: On April 7, 2026, FDA issued a Form 483 with 1 observation to Catalent Massachusetts, LLC in Chelsea, Massachusetts (FEI 3011696115) after an inspection that ran Apr 1 – Apr 7, 2026. The investigators were Armen H. Youssoufian and Ogechi C. Nna. Most observations concern production; the most-cited regulation is 21 CFR 211.100 (written procedures; deviations).

At a glance

1 of 1 observations on this 483 concern production.

Production1

Most cited: 21 CFR 211.100 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Written production and process control procedures are not followed in the execution of production…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Catalent Massachusetts, LLC?

FDA listed 1 observation on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.100 (written procedures; deviations). The opening words of each observation are shown on this page.

Who inspected Catalent Massachusetts, LLC?

Armen H. Youssoufian and Ogechi C. Nna are named on this Form 483, for the inspection of Apr 1 – Apr 7, 2026. Each investigator has a profile showing what they cite most.

When was Catalent Massachusetts, LLC inspected by FDA?

The inspection ran Apr 1 – Apr 7, 2026, and the Form 483 is dated April 7, 2026.

How do I get the full Form 483 for Catalent Massachusetts, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free